Curia reconocida en la lista de las 10 principales empresas de CDMO de 2023 de India Pharma Outlook en la India
December 05, 2023 14:21 ET
|
Curia Global, Inc.
ALBANY, Nueva York, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Curia, una organización líder de investigación, desarrollo y fabricación por contrato, anunció hoy que fue reconocida como una de las 10...
Curia Entra para a Lista das 10 Melhores Empresas CDMO de 2023 da India Pharma Outlook
December 05, 2023 14:21 ET
|
Curia Global, Inc.
ALBANY, N.Y., Dec. 05, 2023 (GLOBE NEWSWIRE) -- A Curia, uma organização líder em contratos de pesquisa, desenvolvimento e fabricação, anunciou hoje que entrou para a para a lista das 10 Melhores...
Curia Diiktiraf dalam India Pharma Outlook 2023 10 Syarikat CDMO Terbaik Di India
December 05, 2023 14:21 ET
|
Curia Global, Inc.
ALBANY, N.Y., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Curia, sebuah organisasi penyelidikan, pembangunan dan pembuatan kontrak terkemuka, hari ini umumkan ia diiktiraf sebagai antara 10 CDMO teratas...
Curia von India Pharma Outlook auf der Liste der 10 besten CDMO-Unternehmen in Indien für 2023 aufgeführt
December 05, 2023 14:21 ET
|
Curia Global, Inc.
ALBANY, New York, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Curia, ein führendes Auftragsforschungs-, Entwicklungs- und Produktionsunternehmen, hat heute bekanntgegeben, dass es von India Pharma Outlook...
Curia Recognized on India Pharma Outlook’s 2023 List of Top 10 CDMO Companies in India
December 05, 2023 09:00 ET
|
Curia Global, Inc.
ALBANY, N.Y., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Curia, a leading contract research, development and manufacturing organization, today announced it has been recognized as one of the top 10 CDMOs in...
Curia Supports Replicate Bioscience’s Phase 1 Clinical Trial of Novel Next-Generation RNA Vaccine
September 13, 2023 09:00 ET
|
Curia Global, Inc.
ALBANY, N.Y., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Curia, a leading contract research, development and manufacturing organization, today announced that its partner, Replicate Bioscience, has received...
A Curia apoia o ensaio clínico de fase 1 da nova vacina de RNA de última geração da Replicate Bioscience
September 13, 2023 09:00 ET
|
Curia Global, Inc.
ALBANY, N.Y., Sept. 13, 2023 (GLOBE NEWSWIRE) -- A Curia, uma organização líder em pesquisa, desenvolvimento e fabricação por contrato, anunciou hoje que sua parceira, Replicate Bioscience, recebeu...
Curia Sokong Percubaan Klinikal Fasa 1 Replicate Bioscience bagi Novel Vaksin RNA Generasi Seterusnya
September 13, 2023 09:00 ET
|
Curia Global, Inc.
ALBANY, N.Y., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Curia, sebuah organisasi penyelidikan, pembangunan dan pembuatan kontrak terkemuka, hari ini mengumumkan bahawa rakan kongsinya, Replicate...
キュリア（Curia）、レプリケート・バイオサイエンス（Replicate Bioscience）の新規次世代RNAワクチン向け第一フェーズ臨床治験を支援
September 13, 2023 09:00 ET
|
Curia Global, Inc.
ニューヨーク、アルバニー, Sept. 13, 2023 (GLOBE NEWSWIRE) --...
Curia unterstützt die klinische Studie der Phase 1 von Replicate Bioscience mit einem neuartigen RNA-Impfstoff der nächsten Generation
September 13, 2023 09:00 ET
|
Curia Global, Inc.
ALBANY, N.Y., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Curia, ein führendes Auftragsforschungs-, Entwicklungs- und Produktionsunternehmen, gab heute bekannt, dass sein Partner Replicate Bioscience die...